CryoPort, Inc. - Common Stock (CYRX)

19.23
+3.18 (19.81%)
NASDAQ · Last Trade: Nov 6th, 1:11 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close16.05
Open17.50
Bid19.20
Ask19.26
Day's Range17.17 - 19.53
52 Week Range7.610 - 18.88
Volume1,426,843
Market Cap962.83M
PE Ratio (TTM)-21.13
EPS (TTM)-0.9
Dividend & YieldN/A (N/A)
1 Month Average Volume978,826

Chart

About CryoPort, Inc. - Common Stock (CYRX)

Cryoport Inc is a leading provider of temperature-controlled logistics solutions for the life sciences sector, specializing in the transportation and storage of biological materials. The company offers a comprehensive suite of services designed to ensure the integrity and safety of critical shipments, such as pharmaceuticals, cell and gene therapies, and clinical trial materials. By leveraging advanced technologies and a global network of facilities, Cryoport facilitates the seamless movement of sensitive products while adhering to stringent regulatory standards. Their innovative cryogenic solutions play a vital role in supporting the growth and sustainability of the biopharmaceutical industry. Read More

News & Press Releases

Cryoport (CYRX) Q3 2026 Earnings Call Transcriptfool.com
Services growth and a raised outlook headline a strong cell therapy logistics quarter.
Via The Motley Fool · November 6, 2026
CryoPort Q3 Earnings Call Highlightsmarketbeat.com
CryoPort (NASDAQ:CYRX) raised its full-year 2026 revenue outlook after reporting third-quarter revenue growth of 14%, supported by demand for its cell and gene therapy services and cryogenic products. The company reported revenue of $50.2 million and adjusted earnings before interest, taxes, deprec
Via MarketBeat · November 6, 2026
Cryoport (NASDAQ:CYRX) Q3 Revenue In Line, EPS Miss, Shares Rally After Hourschartmill.com
Via Chartmill · November 5, 2026
Cryoport (CYRX) Q2 2026 Earnings Call Transcriptfool.com
CGT services revenue surged 15% as clinical trial support expanded to 779 trials globally.
Via The Motley Fool · August 14, 2026
Cryoport (NASDAQ:CYRX) Reports In-Line Q2 Results as Stock Edges Higherchartmill.com
Via Chartmill · August 6, 2026
Cryoport Inc (NASDAQ:CYRX) Reports Q1 2026 Revenue Beat Amid Wider Net Loss and Cautious Full-Year Outlookchartmill.com
Via Chartmill · May 4, 2026
Cryoport Inc (NASDAQ:CYRX) Reports Mixed Q4 2025 Results with Revenue Beat but Persistent Losseschartmill.com
Via Chartmill · March 3, 2026
CryoPort Q2 Earnings Call Highlightsmarketbeat.com
CryoPort (NASDAQ:CYRX) reported second-quarter 2026 revenue of $49 million and said it reached positive adjusted EBITDA from continuing operations, while reaffirming its full-year revenue outlook of $192 million to $196 million. Chief Executive Officer Jerrell Shelton said revenue momentum continue
Via MarketBeat · August 6, 2026
Cryoport (CYRX) Q1 2026 Earnings Transcriptfool.com
Cryoport (CYRX) Q1 2026 Earnings Transcript
Via The Motley Fool · May 4, 2026
Cryoport (CYRX) Q2 2025 Earnings Transcriptfool.com
Cryoport (CYRX) Q2 2025 Earnings Transcript
Via The Motley Fool · May 4, 2026
Earnings Scheduled For November 4, 2025benzinga.com
Via Benzinga · November 4, 2025
Analyst Expectations For CryoPort's Futurebenzinga.com
Via Benzinga · September 18, 2025
Cryoport (CYRX) Q1 2025 Earnings Transcriptfool.com
Cryoport (CYRX) Q1 2025 Earnings Transcript
Via The Motley Fool · May 4, 2026
Cryoport (CYRX) Q3 2025 Earnings Transcriptfool.com
Cryoport (CYRX) Q3 2025 Earnings Transcript
Via The Motley Fool · May 4, 2026
Cryoport (CYRX) Q4 2025 Earnings Call Transcriptfool.com
Cryoport (CYRX) Q4 2025 Earnings Call Transcript
Via The Motley Fool · March 3, 2026
Cryoport Reports Strong Q3 Results, Raises FY25 Outlookbenzinga.com
Cryoport Inc (NASDAQ:CYRX) reports third-quarter financial results after the market close on Tuesday. Here's a rundown of the report.
Via Benzinga · November 4, 2025
Alphabet To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursdaybenzinga.com
Via Benzinga · September 18, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · August 6, 2025
Here are the top movers in Wednesday's session.chartmill.com
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · August 6, 2025
Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
Via Benzinga · August 6, 2025
The market is filled with gapping stocks in Wednesday's session.chartmill.com
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · August 6, 2025
Expert Outlook: CryoPort Through The Eyes Of 4 Analystsbenzinga.com
Via Benzinga · August 6, 2025
Discover the top movers in Wednesday's pre-market session.chartmill.com
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via Chartmill · August 6, 2025
Cryoport (CYRX) Q2 Revenue Jumps 14%fool.com
Via The Motley Fool · August 6, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · August 6, 2025